Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Maki, Yoshimitsu"'
Autor:
Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Katsuhiro Okuda, Keisuke Yokota, Shinji Kano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative dam
Externí odkaz:
https://doaj.org/article/1aa32c0a1f074e7a93a843d40b0dbb97
Autor:
Hiroshi Kato, Shinji Kano, Yukiko Yasui, Yuka Nojiri, Maki Yoshimitsu, Motoki Nakamura, Akimichi Morita
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1007-1012 (2023)
The most important driver gene in malignant melanoma is the BRAF mutation, and molecularly targeted therapies targeting mutations, mainly V600E and V600k, are used in clinical practice. In this report, we treated a patient with malignant melanoma exp
Externí odkaz:
https://doaj.org/article/a71723fb5ed844b09ac565dabc866550
Autor:
Tetsuya Magara, Motoki Nakamura, Yuka Nojiri, Maki Yoshimitsu, Shinji Kano, Hiroshi Kato, Akimichi Morita
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Cutaneous angiosarcoma (CAS) is a highly malignant tumor with few effective treatments. Although the indication for immune checkpoint inhibitors such as anti-PD-1 antibodies is expected to expand, there are many unknowns regarding the tumor immune mi
Externí odkaz:
https://doaj.org/article/361a97723d6740989e3ca2e6295197a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shinji Kano, Motoki Nakamura, Yuka Nojiri, Tetsuya Magara, Maki Yoshimitsu, Hiroshi Kato, Akimichi Morita
Publikováno v:
Journal of Dermatological Science. 109:136-142
Autor:
Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Kotaro Nagase, Maki Yoshimitsu, Tetsuya Magara, Yuka Nojiri, Tadahiro Kobayashi, Yukiko Teramoto, Masahito Yasuda, Hidefumi Wada, Toshiyuki Ozawa, Yukie Umemori, Dai Ogata
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Merkel cell carcinoma (MCC) is a rare and highly malignant skin cancer. Some cases have a good prognosis and spontaneous regression can occur. Reported prognostic markers, such as Merkel cell polyoma virus infection or programmed death lig
Externí odkaz:
https://doaj.org/article/2f5725b1c69c4446b64afea2feedf8dc
Autor:
Ando, Masahiro, Higuchi, Yujiro, Yuan, Junhui, Yoshimura, Akiko, Kojima, Fumikazu, Yamanishi, Yuki, Aso, Yasuhiro, Izumi, Kotaro, Imada, Minako, Maki, Yoshimitsu, Nakagawa, Hiroto, Hobara, Takahiro, Noguchi, Yutaka, Takei, Jun, Hiramatsu, Yu, Nozuma, Satoshi, Sakiyama, Yusuke, Hashiguchi, Akihiro, Matsuura, Eiji, Okamoto, Yuji
Publikováno v:
Annals of Clinical & Translational Neurology; Jan2024, Vol. 11 Issue 1, p96-104, 9p
Autor:
Akimichi Morita, Hiroshi Kato, Akihiro Matsubara, Shinji Kano, Maki Yoshimitsu, Yuka Nojiri, Motoki Nakamura, Tetsuya Magara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b3254fef7d732d3e0d404a9eb453163
https://doi.org/10.26226/m.62fa00a04b6034001b1c317a
https://doi.org/10.26226/m.62fa00a04b6034001b1c317a